The US cell counting market is projected to grow at a significant CAGR during the forecast period (2020-2026). The penetration and rising applications of cell-based research in the biopharmaceutical industry is the major factor that is driving the growth of the market in the country.
Cell culture is widely being used in the US biopharmaceutical industries for vaccine production, drug development, tissue culture, and engineering, and the production of monoclonal antibodies and therapeutics for cancer. The US biopharmaceutical sector provides important R&D investments supporting new treatments and potential cures that improve the health and well being of individuals.
(Get 15% Discount on Buying this Report)
A full report of US Cell Counting Market is available at: https://www.omrglobal.com/industry-reports/us-cell-counting-market
One of the major factors that account for the US as the significant market for cell counting is the high healthcare spending. The US spends more on healthcare than any other developed economy. The reason for more healthcare expenditure is the large GDP growth of the nation. According to the National Health Expenditure Accounts (NHEA), US health care spending grew 4.3% in 2018, reaching $3.3 trillion or $10,348 per person. It accounts for about 18% of the GDP on healthcare spending augmenting the market for cancer treatment and diagnosis. Therefore the increase in the expenditure for cancer care is further projected to provide ample opportunity to the cell counting industry.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/us-cell-counting-market
Market Coverage
- Study Period- 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segments Covered- By Product Type, by Application, and by End-User
- Key Companies Profiled- Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Danahar Corp., Thermo Fisher Scientific Inc., Perkinelmer, Inc., and others
Key Questions Addressed by the Report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
US Cell Counting Market – Segmentation
By Product Type
- Instruments
- Consumables
By Application
- Medical Applications
- Research
- Industrial
By End-User
- Pharmaceuticals and Biotechnology companies
- Research Institutes and CRO
- Hospitals and Diagnostic Laboratories
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
